Drugs / Rituximab and Hyaluronidase Human
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04626791 Background | Aug 2021 → Aug 2024 overdue | mantle cell lymphoma | Academic and Community Cancer Research United | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rituximab and Hyaluronidase Human | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04626791 ↗ |
| Route | Intravenous | “Given IV” NCT04626791 ↗ |